Posters 7. Microbiology − Diagnosis and epidemiology S83 135 The use of rep-PCR (Diversilab ® , bioMérieux) in combination with multiplex PCR (targeting virulence genes) reveals the transmission of Pseudomonas aeruginosa isolates among cystic fibrosis patients in a hospital background Objectives: To rapidly detect transmission of Pseudomonas aeruginosa (P. aeruginosa) among cystic fibrosis (CF) patients in a hospital environment, so that the necessary measures can be taken to avoid future transmissions. Methods: The use of molecular typing techniques such as rep-PCR (Diversilab ® , bioMérieux)
Background: Pseudomonas aeruginosa (PA) is one of a few bacteria emitting the poisonous gas hydrogen cyanide (HCN) to effectively outmatch competitive flora using HCN synthase to produce HCN from glycine under microaerobic conditions. Methods: Surface-Enhanced Raman Spectroscopy (SERS) is a method which holds great potential in the detection of small molecules at very low concentrations because our nanostructured SERS surface enhances the Raman signal >1,000,000 times. Objectives: The objective of the project is to further develop the nanostructured SERS chip originally made for explosives detection to build a point-of-care sensor able to detect hydrogen cyanide emissions in the breath of PA infected CF patients. Results: In a serial dilution experiment on the SERS chip a direct proportional relationship between the concentration of applied cyanide and the resulting enhanced Raman signal was demonstrated. SERS measurements on physiologically relevant concentrations of HCN gas will be presented as well as incubation results of the SERS chip with PA in various environments. Conclusion: Using our SERS chip it is possible to measure HCN at physiologically relevant concentrations demonstrating the potential of detecting PA at an earlier stage than allowed by current technology. Background: The definitions of "chronic" and "new/early" infection are assessed retrospectively. In order for these definitions to be consistently applied in research practice, standardised clinical practice is required. Objectives: To gain information on clinical practice within ECFS-CTN sites with regards sampling and processing of respiratory samples for identification of P. aeruginosa. Methods: A survey was distributed to investigators in all ECFS-CTN sites. Results: 43 sites/subsites completed the survey giving a representative sample of the whole group. 72% of sites had both adult and paediatric patients registered, with remaining centres having either adults only (14%) or paediatrics only (14%). 52% of ECFS-CTN sites collected respiratory samples for routine culture at least every 3 months (5% monthly; 43% at every hospital visit). In adult patients this was predominantly sputum. Sites with only paediatric patients and sites with both adults and paediatrics use a combination of sputum and oropharyngeal swabs. For patients unable to expectorate, sites had different strategies for escalating to more invasive methods of obtaining samples (i.e. sputum induction and bronchoalvaolar lavage). The two main reasons for performing invasive sampling were unexplained clinical deterioration and suspicion of non-tuberculous mycobacteria. There was great variability in laboratory practices reported for processing (e.g. homogenisation of samples, medium used, methods used to confirm identity of P. aeruginosa). Conclusion: This survey highlights the challenges to research in applying definitions for infection retrospectively using clinical data.
